ovarian hyperstimulation syndrome
Showing 26 - 44 of 44
Ovarian Hyperstimulation Syndrome Trial in Tehran (Cabergoline, Control)
Completed
- Ovarian Hyperstimulation Syndrome
-
Tehran, Iran, Islamic Republic ofEndocrinology and Female Infertility Department, Reproductive Me
May 5, 2015
Early Follicular Phase With Androstenedione in Low-dose Step-up
Unknown status
- Infertility
- Ovarian Hyperstimulation Syndrome
-
Istanbul, TurkeyBagcilar Training and Research Hospital
Apr 4, 2015
Ovarian Hyperstimulation Syndrome Trial in Athens (cetrorelix (cetrotide), Placebo)
Unknown status
- Ovarian Hyperstimulation Syndrome
- cetrorelix (cetrotide)
- Placebo
-
Athens, GreeceEugonia Unit of Assisted Reproduction
Mar 18, 2015
Oxidative Stress Markers in Ovarian Hyperstimulation Patients
Unknown status
- Ovarian Hyperstimulation Syndrome
-
Ankara, TurkeyT.C Saglik Bakanligi Etlik Zübeyde Hanim Womens Health Teaching
Jul 24, 2014
Ovarian Hyperstimulation Syndrome Trial in Cairo (calcium, 0.9 % saline)
Completed
- Ovarian Hyperstimulation Syndrome
- calcium
- 0.9 % saline
-
Cairo, Cario, EgyptKasr elini hospital
Jul 8, 2014
Long Acting GnRH Antagonist in PCOS Women Undergoing IVF
Unknown status
- Polycystic Ovarian Syndrome
- +2 more
- GnRH antagonist depot Degarelix
-
Rome, ItalyBioroma
Mar 11, 2014
Ovarian Hyperstimulation Syndrome, Effects of Gonadotropin, Oocyte Maturation Trial in Valencia (GnRH antagonist (Cetrorelix),
Completed
- Ovarian Hyperstimulation Syndrome
- +2 more
- GnRH antagonist (Cetrorelix)
- Placebo (saline solution)
-
Valencia, SpainIVI Valencia
Sep 18, 2013
Ovarian Hyperstimulation Syndrome Trial in Reston (Cetrotide acetate)
Completed
- Ovarian Hyperstimulation Syndrome
- Cetrotide acetate
-
Reston, VirginiaVirginia Center for Reproductive Medicine
Mar 26, 2013
Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist
Completed
- Ovarian Hyperstimulation Syndrome
-
Augsburg, Germany
- +9 more
Jun 13, 2012
Polycystic Ovarian Syndrome, Ovarian Hyperstimulation Syndrome Trial (Cabergoline)
Completed
- Polycystic Ovarian Syndrome
- Ovarian Hyperstimulation Syndrome
- (no location specified)
Apr 3, 2012
Ovarian Hyperstimulation Syndrome Trial in New Haven (Human Albumin Infusion, Saline Infusion)
Withdrawn
- Ovarian Hyperstimulation Syndrome
- Human Albumin Infusion
- Saline Infusion
-
New Haven, ConnecticutYale Fertility Center
Feb 20, 2012
Double GnRH Antagonist Daily Dose in Hyperresponding IVF/ICSI
Completed
- Ovarian Hyperstimulation Syndrome
- (no location specified)
Nov 23, 2011
Ovarian Hyperstimulation Syndrome Trial in Tehran (Methylprednisolone, Control)
Completed
- Ovarian Hyperstimulation Syndrome
-
Tehran, Iran, Islamic Republic ofRoyan Institute
Jul 14, 2011
Ovarian Hyperstimulation Syndrome Trial in Valencia (Quinagolide)
Completed
- Ovarian Hyperstimulation Syndrome
-
Valencia, SpainInstituto Valenciano de Infertilidad
Sep 16, 2009
Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome Trial in Ramat-Gan (In Vitro Maturation of immature oocytes)
Completed
- Polycystic Ovary Syndrome
- Ovarian Hyperstimulation Syndrome
- In Vitro Maturation of immature oocytes
-
Ramat-Gan, IsraelIVF Unit, Shea Medical Center, Tel-Hashomer
Dec 16, 2008
Ovarian Hyperstimulation Syndrome Trial (Cabergoline, MR, Ultrasound)
Completed
- Ovarian Hyperstimulation Syndrome
- Cabergoline
- +3 more
- (no location specified)
Feb 26, 2007
Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome Trial in Athens (Arvekap 0.1mg (Triptorelin, Ipsen, France),
Unknown status
- Polycystic Ovary Syndrome
- Ovarian Hyperstimulation Syndrome
- Arvekap 0.1mg (Triptorelin, Ipsen, France)
- Ganirelix 0.25mg (Orgalutran, Organon, The Netherlands)
-
Athens, GreeceEugonia
Dec 28, 2006
Ovarian Hyperstimulation Syndrome Trial in Farmington (Leuprolide acetate)
Completed
- Ovarian Hyperstimulation Syndrome
- Leuprolide acetate
-
Farmington, ConnecticutCenter for Advanced Reproductive Services, UCHC
Jul 5, 2006